Lennarth Nyström

TL;DR: The advantageous effect of breast screening on breast cancer mortality persists after long-term follow-up, and the recent criticism against the Swedish randomised controlled trials is misleading and scientifically unfounded.

TL;DR: There was a consistent risk reduction associated with screening in all studies, although the point estimate of the relative risk for all ages varied non-significantly between 0.68 and 0.84.

TL;DR: From a systematic literature review of European trend studies, the best ‘European’ estimate of breast cancer mortality reduction is 25–31% for women invited for screening, and 38–48% for Women actually screened.

TL;DR: The ecological observations made in this study are compatible with the epidemic being the result of a change in and an interplay among three factors within the area of infant feeding, i.e. amount of gluten given, age at introduction of gluten, and whether breastfeeding was ongoing or not when gluten was introduced.

TL;DR: Although there is evidence for a reduction in breast carcinoma mortality with mammographic screening, some doubts have been expressed, and there is still uncertainty regarding the age specific effects.